valerates has been researched along with colforsin in 1 studies
Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
---|---|---|---|---|---|
2,251 | 294 | 457 | 13,460 | 46 | 1,298 |
Protein | Taxonomy | valerates (IC50) | colforsin (IC50) |
---|---|---|---|
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banić, A; Kouris, K; Nazal, M; Rajacić, N; Thulesius, O | 1 |
1 other study(ies) available for valerates and colforsin
Article | Year |
---|---|
Increased skin flap viability after treatment with forskolin or with ridogrel, a thromboxane synthesis inhibitor and receptor blocker.
Topics: Animals; Colforsin; Graft Survival; Male; Microcirculation; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Skin; Surgical Flaps; Thromboxane A2; Valerates | 1990 |